Millennium Management
AVDL

Millennium Management’s Avadel Pharmaceuticals AVDL Stock Holding History

Millennium Management’s Portfolio AVDL Stock Details AVDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-50,000
Closed -$342K – 6956
2022
Q1 		$342K Buy
+50,000
New +$344K ﹤0.01% 5438

Other funds holding AVDL

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Millennium Management's AVDL Position: Q1 2026 in Review

Millennium Management sold out of Avadel Pharmaceuticals (AVDL) in Q1 2026, closing a stake of 84,085 shares — an estimated $1.81M sold.

Millennium Management first reported a position in AVDL in Q2 2013 and held it in 43 quarters. The position peaked at $32.9M in Q1 2015. 2 funds tracked by Wall St. Rank hold AVDL as of Q1 2026.

  • Millennium Management reported no remaining Avadel Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Millennium Management sold 84,085 Avadel Pharmaceuticals shares in Q1 2026, an estimated $1.81M.
  • Millennium Management first reported a position in Avadel Pharmaceuticals in Q2 2013 and held it in 43 quarters.
  • Millennium Management's Avadel Pharmaceuticals position peaked at $32.9M in Q1 2015.
  • 2 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.